Compare TRNS & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRNS | PTA |
|---|---|---|
| Founded | 1964 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 807.1M | 942.4M |
| IPO Year | 1995 | N/A |
| Metric | TRNS | PTA |
|---|---|---|
| Price | $81.84 | $16.87 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $104.33 | N/A |
| AVG Volume (30 Days) | 115.3K | ★ 308.3K |
| Earning Date | 11-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $331,877,000.00 | N/A |
| Revenue This Year | $12.37 | N/A |
| Revenue Next Year | $6.64 | N/A |
| P/E Ratio | $585.00 | ★ N/A |
| Revenue Growth | ★ 19.20 | N/A |
| 52 Week Low | $50.23 | $16.66 |
| 52 Week High | $100.00 | $20.15 |
| Indicator | TRNS | PTA |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 37.50 |
| Support Level | $79.35 | $16.66 |
| Resistance Level | $93.82 | $19.53 |
| Average True Range (ATR) | 2.84 | 0.19 |
| MACD | -0.41 | 0.03 |
| Stochastic Oscillator | 20.26 | 41.82 |
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its main investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.